Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
데이터 추가 비고
원인
Treatment plans for the brainlab m3 micro-multileaf collimator (micro-mlc) typically contain closed leaf pairs. ideally no dose should be delivered through the small gap remainning between the closed leaf tips. however a certain leakage is technically unavoidable unless this leaf gap is covered by the linac collimator (jaws).